Insulet (PODD) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Insulet Reports First Quarter 2016 Financial Results
April 28, 2016 4:02 PM EDTBILLERICA, Mass., April 28, 2016 /PRNewswire/ -- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today announced financial results for the three months ended March 31, 2016.       Â
First Quarter Highlights and Recent Developments:
First quarter revenue of $81.2 million exceeds the Company's guidance of $77 to $80 million and represents year-over-year growth of 69%. U.S. OmniPod revenue of $50.7 million, an increase of 28%. International OmniPod revenue of $15.4 million, an increase of 307%. Drug Delivery revenue of $15.1... More